Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19 Oral Antiviral Agents

Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19.
Renslow Sherer, MD
Released: January 6, 2022

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir—for nonhospitalized adults with mild to moderate COVID-19, including:

  • EPIC-HR study of nirmatrelvir (PF-07321332) plus ritonavir
    • Safety data
    • Efficacy data
  • MOVe-OUT study of molnupiravir
    • Safety data
    • Efficacy data
  • Roles in treatment of COVID-19
    • Timing of treatment

Information on this Educational Activity

Faculty

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has disclosed that he has received funds for research support from Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

European expert summaries of the outpatient management of acute COVID-19 and long COVID, from Clinical Care Options (CCO)

Jens D. Lundgren, MD, DMSc Barbara Rath, MD, PhD, HDR Released: February 1, 2023

This downloadable PDF reviews a treatment pathway for nonhospitalized patients with COVID-19, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Renslow Sherer, MD Released: January 17, 2023

Dr Stephaun Elite Wallace on COVID-19 inequities in BIPOC communities and strategies to minimize these disparities, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Stephaun Elite Wallace, PhD, MS Released: January 17, 2023

Clinical Care Options (CCO) podcast with Drs. Jens Lundgren and Barbara Rath on acute COVID-19 and long COVID in Europe.

Jens D. Lundgren, MD, DMSc Barbara Rath, MD, PhD, HDR Released: January 13, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings